Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

Prescription-drug prices

Article Abstract:

A prescription-drug benefit is added to the Medicare program through the Medicare Modernization Act that helps in reshaping the government's role as a payer for prescription drugs. The prices that the government pays for prescription drugs would be critically important, as they would affect the cost of the new drug benefit, the financial stability of the Medicare program, and incentives for prescription-drug manufacturers to develop new pharmaceutical agents.

Author: Frank, Richard G.
Publisher: Massachusetts Medical Society
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 2004
Commodity & service prices, Prices and rates, Company pricing policy

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Drug-induced hepatotoxicity

Article Abstract:

The mechanisms by which some drugs damage the liver are reviewed. Topics include hepatic biotransformation, types of reactions, targets of cell injury, clinical consequences, acetaminophen toxicity, drug-related liver damage in patients with liver disease, and the diagnosis and treatment of drug-induced liver damage. In the late 1990s, Duract and Rezulin were both withdrawn from the market because they caused liver damage in some patients.

Author: Lee, William M.
Publisher: Massachusetts Medical Society
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 2003
Causes of, Complications and side effects, Liver diseases

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Drugs and the QT interval-caveat doctor

Article Abstract:

A number of drugs are removed from the market or required to include 'black box' warnings on their labels because of the potential for drug-induced prolongation of the QT interval. It is suggested that the patients with other preexisting drug-related or non-drug-related risk factors should use QT-interval-prolonging drugs very cautiously after weighing the benefits and risks on a case-by-case basis.

Author: Juurlink, David N., Liu, Barbara A.
Publisher: Massachusetts Medical Society
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 2004
Labeling

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Pharmaceutical industry, Drugs
Similar abstracts:
  • Abstracts: Hospitals binge on practice buy-outs. Savings may be FTC test in hospital, doctor mergers. Justice Dept. squelches Baton Rouge PHO
  • Abstracts: Three basic principles of success. Applying statistics to the dental practice. Dental business management
  • Abstracts: Healing hearts. Developing roles in critical care outreach. The critical care dream team: Sheila Adam and her team run a pioneering critical care service that covers an entire hospital
  • Abstracts: Provision of palliative care education in nursing homes. Education and job cuts have been 'too sharp'
  • Abstracts: Ban on intact D&X passes in the Senate. Prescription monitoring on tap in Florida
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.